Sunesis Pharmaceuticals
| Region | Nordamerika |
| ISIN | US8673288747 |
| Sektor | Biotechnologie |
| Website | https://www.sunesis.com/ |
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.
| Titel | Autor | Datum |
|---|---|---|
|
Risikoarmes "Peak Play" mit Multibagger-Potenzial
|
sharedeals | vor über 1 Jahren |
| Titel | Datum |
|---|---|
| MISC rises to highest since Nov 2020 as KLCI declines | vor ungefähr 4 Monaten |
| Lloyd's Register, Samsung Heavy Industries and MISC ink MOU for zero-emission VLCCs | vor ungefähr 4 Monaten |
| Moody's assigns provisional Baa2 rating to MISC MTN programme | vor ungefähr 4 Monaten |
| MISC poised to continue uptrend, says RHB Retail Research | vor ungefähr 5 Monaten |
| MISC unit to undertake Global Medium Term Note programme of up to US$3b | vor ungefähr 5 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Suedzucker (1 Artikel) | |
| Stockholm IT Ventures AB (1 Artikel) | |
| Tahoe Resources (1 Artikel) | |
| Telit Communications (3 Artikel) | |
| Alle anzeigen | |